• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Product Image

Cardiovascular Monitoring and Diagnostic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

  • ID: 2888535
  • May 2014
  • Region: Global
  • 100 Pages
  • Transparency Market Research

FEATURED COMPANIES

  • Covidien plc
  • GE Healthcare
  • Johnson & Johnson
  • Nihon Kohden Corporation
  • Sorin Group
  • St. Jude Medical, Inc.
  • MORE

This report covers the market analysis for various devices used for diagnosing and monitoring of cardiovascular diseases. The stakeholders for this study include the present manufacturers and providers of cardiovascular diagnostic and monitoring devices as well as the new players who desire to enter this market.

The market overview section of the report details about the market dynamics and trends such as the drivers, restraints and opportunities that have an impact on the current and future condition of this market. Degree of market attractiveness is explained through Porter's five forces analysis and the most attractive market by geography is represented in the market attractiveness analysis section of this report.

The global cardiovascular monitoring and diagnostic devices market is differentiated into six segments based on the product type. The products analyzed in this study are the ECG systems, cardiovascular diagnostics catheters, event monitors, holter monitors, implantable loop recorders and ECG management systems. ECG systems are further analyzed on the basis of its types available in market namely the resting ECG and stress ECG. The market forecast for all these READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Covidien plc
  • GE Healthcare
  • Johnson & Johnson
  • Nihon Kohden Corporation
  • Sorin Group
  • St. Jude Medical, Inc.
  • MORE

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.4 Research Methodology
1.5 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Cardiovascular Monitoring and Diagnostic Devices Market
2.2 Comparative Analysis: Global Cardiovascular Monitoring and Diagnostic Devices, by Geography, 2012 & 2019 (Value %)

Chapter 3 Global Cardiovascular Monitoring and Diagnostic Devices Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Increase in the risk of cardiovascular diseases with aging population
3.2.2 Increase in medical tourism
3.2.3 Changing lifestyle habits increasing the risk for cardiovascular diseases
3.3 Market Restraints
3.3.1 Lack of adequate reimbursement
3.3.2 Higher device cost limiting the demand in developing regions
3.4 Market Opportunities
3.4.1 Lucrative market opportunities in emerging economies
3.4.2 Emergence of new technologies with affordable price
3.5 Porter's Five Forces Analysis for the Global Cardiovascular Monitoring and Diagnostic Devices Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography

Chapter 4 Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type
4.1 Overview
4.1.1 Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type, 2011 - 2019 (USD Million)
4.2 Comparative Analysis: Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type, 2012 & 2019 (Value %)
4.3 ECG Systems
4.3.1 Global ECG Systems Market Revenue, by Product Type, 2011 - 2019 (USD Million)
4.3.2 Resting ECG Systems
4.3.2.1 Global Resting ECG Systems Market Revenue, 2011 - 2019 (USD Million)
4.3.2.2 Global Resting ECG Systems Market Volume, 2011 - 2019 (Number of Units)
4.3.3 Stress ECG Systems
4.3.3.1 Global Stress ECG Systems Market Revenue, 2011 - 2019 (USD Million)
4.3.3.2 Global Stress ECG Systems Market Volume, 2011 - 2019 (Number of Units)
4.4 Diagnostic Catheters
4.4.1 Global Diagnostic Catheters Market Revenue, 2011 - 2019(USD Million)
4.4.2 Global Diagnostic Catheters Market Volume, 2011 - 2019 (Number of Units)
4.5 Event Monitors
4.5.1 Global Event Monitors Market Revenue, 2011 - 2019 (USD Million)
4.5.2 Global Event Monitors Market Volume, 2011 - 2019 (Number of Units)
4.6 Holter Monitor
4.6.1 Global Holter Monitors Market Revenue, 2011 - 2019 (USD Million)
4.6.2 Global Holter Monitors Market Volume, 2011 - 2019 (Number of Units)
4.7 Implantable Loop Recorders
4.7.1 Global Implantable Loop Recorders Market Revenue, 2011 - 2019 (USD Million)
4.7.2 Global Implantable Loop Recorders Market Volume, 2011 - 2019 (Number of Units)
4.8 ECG Management Systems
4.8.1 Global ECG Management Systems Market Revenue, 2011 - 2019 (USD Million)
4.8.2 Market Share Analysis for Global ECG Management Systems Market, by Key Players, 2012 (Value %)

Chapter 5 Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Geography
5.1 Overview
5.1.1 Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Geography, 2011 - 2019 (USD Million)
5.2 North America
5.2.1 North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)
5.3 Europe
5.3.1 Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)
5.4 Asia-Pacific
5.4.1 Asia-Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)
5.5 Rest of the World (RoW)
5.5.1 Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Recommendations

Chapter 7 Company Profiles
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Covidien plc
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 FUKUDA DENSHI Co., Ltd.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 GE Healthcare
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Johnson & Johnson
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Medtronic, Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Nihon Kohden Corporation
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Development
7.8 Philips Healthcare
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 Siemens Healthcare
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
7.10 Sorin Group
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments
7.11 Spacelabs Healthcare
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Product Portfolio
7.11.4 Business Strategies
7.11.5 Recent Developments
7.12 St. Jude Medical, Inc.
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Product portfolio
7.12.4 Business Strategies
7.12.5 Recent Developments
7.13 Welch Allyn
7.13.1 Company Overview
7.13.2 Financial Overview
7.13.3 Product Portfolio
7.13.4 Business Strategies
7.13.5 Recent Developments

List of Figures

FIG. 1 Cardiovascular Monitoring and Diagnostic Devices Market Segmentation
FIG. 2 Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography, 2012 & 2019 (Value %)
FIG. 4 Global Population, by Age-Group, 2000 & 2050 (%)
FIG. 5 Porter's Five Forces Analysis for the Global Cardiovascular Monitoring and Diagnostic Devices Market
FIG. 6 Market Attractiveness Analysis of the Global Cardiovascular Monitoring and Diagnostic Devices Market, by Geography
FIG. 7 Comparative Analysis: Global Cardiovascular Monitoring and Diagnostic Devices Market, by Product Type, 2012 & 2019 (Value %)
FIG. 8 Global Resting ECG Systems Market Revenue, 2011 - 2019 (USD Million)
FIG. 9 Global Resting ECG Systems Market Volume, 2011 - 2019 (Number of Units)
FIG. 10 Global Stress ECG Systems Market Revenue, 2011 - 2019 (USD Million)
FIG. 11 Global Stress ECG Systems Market Volume, 2011 - 2019 (Number of Units)
FIG. 12 Global Diagnostic Catheters Market Revenue, 2011 - 2019 (USD Million)
FIG. 13 Global Diagnostic Catheters Market Volume, 2011 - 2019 (Number of Units)
FIG. 14 Global Event Monitors Market Revenue, 2011 - 2019 (USD Million)
FIG. 15 Global Event Monitors Market Volume, 2011 - 2019 (Number of Units)
FIG. 16 Global Holter Monitors Market Revenue, 2011 - 2019 (USD Million)
FIG. 17 Global Holter Monitors Market Volume, 2011 - 2019 (Number of Units)
FIG. 18 Global Implantable Loop Recorder Market Revenue, 2011 - 2019 (USD Million)
FIG. 19 Global Implantable Loop Recorders Market Volume, 2011 - 2019 (Number of Units)
FIG. 20 Global ECG Management Systems Market Revenue, 2011 - 2019 (USD Million)
FIG. 21 Market Share Analysis: ECG Management Systems Market, by Key Players 2012 (Value %)
FIG. 22 North America Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)
FIG. 23 Europe Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)
FIG. 24 Asia-Pacific Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)
FIG. 25 Rest of the World Cardiovascular Monitoring and Diagnostic Devices Market Revenue, 2011 - 2019 (USD Million)
FIG. 26 Boston Scientific Corporation: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 27 Covidien PLC: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 28 Fukuda Denshi Co., Ltd.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 29 GE Healthcare: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 30 Johnson & Johnson: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 31 Medtronic, Inc.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 32 Nihon Kohden Corporation: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 33 Philips Healthcare: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 34 Siemens Healthcare: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 35 Sorin Group.: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 36 Spacelabs Healthcare: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 37 St. Jude Medical, Inc.: Annual Revenue, 2010 - 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Cardiovascular Monitoring and Diagnostic Devices Market
TABLE 3 Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Product Type, 2011 - 2019 (USD Million)
TABLE 4 Global ECG Systems Market Revenue, by Product Type, 2011 - 2019 (USD Million)
TABLE 5 Global Cardiovascular Monitoring and Diagnostic Devices Market Revenue, by Geography, 2011 - 2019 (USD Million)

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Covidien plc
  • GE Healthcare
  • Johnson & Johnson
  • Nihon Kohden Corporation
  • Sorin Group
  • St. Jude Medical, Inc.
  • MORE

Cardiovascular diseases have been the leading cause of death worldwide and will be the leading cause till 2030, according to World Health Organization (WHO). The major factors which increases the burden of this disease are lifestyle habits such as physical inactivity, smoking and unhealthy diet. These factors which result in obesity and hypertension are also identified as the underlying cause of cardiovascular disorders. The number of people diagnosed with coronary artery disease, peripheral artery disease, pulmonary embolism and congenital heart disease is rising rapidly worldwide. Therefore, the need for preventive healthcare has arisen and realized by countries with high burden of these disorders. Thus, the demand for cardiovascular monitoring and diagnostic devices is expected to rise in such countries.

Aging is one of the major factors driving the demand for cardiovascular monitoring and diagnostic devices. As the aging process advents, the risk of hypertension, weakening of heart muscles, obesity and diabetes grows, thus increasing the risk of cardiovascular diseases. Moreover, advent of new technologies enabling portability in handling and performing the test will drive the global cardiovascular monitoring and diagnostic devices market further. For example, technologies such as implantable loop recorders and wearable heart rate monitors would compel other players in the market to pace up with their product technologies, which will fuel the market growth.

Based on the product type, the global cardiovascular monitoring and diagnostic devices market is categorized into six segments namely ECG systems, cardiovascular diagnostic catheters, holter monitors, event monitors, implantable loop recorders and ECG management systems. Among these, ECG systems held the majority share of the global cardiovascular monitoring and diagnostic devices market in 2012, while the global market for implantable loop recorders is expected to grow at a faster pace during the forecast period. The ECG systems market is majorly dominated by the resting ECG systems owing to higher demand from customers due to convenience in the procedure. The demand for these systems will rise further owing to their lower price and rising demand from patients. Also, it is more convenient to be used among elderly patients and patients at high risk of congestive heart failure.

Geographically, the global cardiovascular monitoring and diagnostic devices market is categorized into four regions namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). North America dominated the global cardiovascular monitoring and diagnostic devices market in 2012 due to high patient awareness coupled with the presence of sophisticated healthcare infrastructure. Also, the adoption of new technologies is rapid in this region which results in high demand for advanced cardiovascular monitoring and diagnostic devices. Conversely, the Asia-Pacific region is expected to grow at a higher CAGR, owing to the high presence of unmet healthcare needs, high patient population and increasing healthcare expenditure.

The global cardiovascular monitoring and diagnostic devices market is characterized by the presence of few big players such as GE Healthcare, Philips Healthcare, Boston Scientific Corporation, Siemens Healthcare, Nihon Kohden Corporation, St. Jude Medical, Inc. and Welch Allyn, Inc. Competition is high among these players which compels them to seek for new technologies and devices providing accurate and convenient testing.

Note: Product cover images may vary from those shown

- Boston Scientific Corporation
- Covidien plc
- FUKUDA DENSHI Co., Ltd.
- GE Healthcare
- Johnson & Johnson
- Medtronic, Inc.
- Nihon Kohden Corporation
- Philips Healthcare
- Sorin Group
- Spacelabs Healthcare
- St. Jude Medical, Inc.
- Welch Allyn
- iemens Healthcare

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos